Histone modifications and skeletal muscle metabolic gene expression

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 3, 2010, Pages 392-396

  McGee, Sean L ^a   Hargreaves, Mark ^b  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Histone deacetylase; Histone modifications; Intracellular signalling; Metabolism; Skeletal muscle

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEASOME; UBIQUITIN;

CONFERENCE PAPER; DISEASE ASSOCIATION; DOWN REGULATION; DRUG MECHANISM; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; INSULIN RESISTANCE; METABOLIC DISORDER; MUSCLE FUNCTION; NONHUMAN; PROTEIN DEGRADATION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION;

ANIMALS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; MUSCLE, SKELETAL;

EID: 77649126244     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05311.x     Document Type: Conference Paper

References (34)

1. DeFronzo RA. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988 37 : 667 687.
2. Wisløff U, Najjar SM, Ellingsen O et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005 307 : 334 335.
3. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003 34 : 267 273.
4. Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 2003 100 : 8466 8471.
5. Strahl BD, Ellis CD. The language of covalent histone modifications. Nature 2000 403 : 41 5.
6. Morris SA, Rao B, Garcia BA et al. Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. J. Biol. Chem. 2007 282 : 7632 7640.
7. McKinsey TA, Zhang CL, Olson EN. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 2001 11 : 497 504.
8. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006 27 : 728 735.
9. Puigserver P, Adelmant G, Wu Z et al. Activation of PPARγ coactivator-1 through transcription factor docking. Science 1999 286 : 1368 1371.
10. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 1998 14 : 167 196.
11. Naya FJ, Black BL, Wu H et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 2002 8 : 1303 1309.
12. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat. Rev. Genet. 2009 10 : 32 42.
13. Fischle W, Dequiedt F, Hendzel MJ et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 2002 9 : 45 57.
14. Potthoff MJ, Wu H, Arnold MA et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 2007 117 : 2459 2467.
15. Backs J, Backs T, Bezprozvannaya S, McKinsey TA, Olson EN. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell. Biol. 2008 28 : 3437 3445.
16. McGee SL, van Denderen BJ, Howlett KF et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 2008 57 : 860 867.
17. Czubryt MP, McAnally J, Fishman GI, Olson EN. Regulation of peroxisome proliferator-activated receptor γ coactivator 1 α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc. Natl Acad. Sci. USA 2003 100 : 1711 1716.
18. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 2008 27 : 1017 1028.
19. Montgomery RL, Potthoff MJ, Haberland M et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 2008 118 : 3588 3597.
20. Choi CS, Befroy DE, Codella R et al. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc. Natl Acad. Sci. USA 2008 105 : 19926 19931.
21. Kemp B, Mitchelhill K, Stapleton D, Michell B, Chen Z, Witters L. Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem. Sci. 1999 24 : 22 5.
22. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase. Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005 1 : 15 25.
23. Holmes BF, Lang DB, Birnbaum MJ, Mu J, Dohm GL. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2004 287 : E739 43.
24. Jørgensen SB, Wojtaszewski JF, Viollet B et al. Effects of α-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J. 2005 19 : 1146 1148.
25. Rozengurt E, Rey O, Waldron RT. Protein kinase D signalling. J. Biol. Chem. 2005 280 : 13205 13208.
26. Dzamko N, Schertzer JD, Ryall JG et al. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J. Physiol. 2008 586 : 5819 5831.
27. 2+-calmodulin- dependent protein kinase II activity in human skeletal muscle. J. Physiol. 2003 553 : 303 309.
28. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim. Biophys. Acta 2008 1782 : 730 743.
29. Connell P, Ballinger CA, Jiang J et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 2001 3 : 93 6.
30. Chung J, Nguyen AK, Henstridge DC et al. HSP72 protects against obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA 2008 105 : 1739 1744.
31. Zhang Y, Fang H, Jiao J, Xu W. The structure and function of histone deacetylases: The target for anti-cancer therapy. Curr. Med. Chem. 2008 15 : 2840 2849.
32. Ficner R. Novel structural insights into class I and II histone deacetylases. Curr. Top. Med. Chem. 2009 9 : 235 240.
33. Takigawa-Imamura H, Sekine T, Murata M, Takayama K, Nakazawa K, Nakagawa J. Stimulation of glucose uptake in muscle cells by prolonged treatment with scriptide, a histone deacetylase inhibitor. Biosci. Biotechnol. Biochem. 2003 67 : 1499 1506.
34. Crunkhorn S, Dearie F, Mantzoros C et al. Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: Potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 2007 282 : 15439 15450.